A major new study analyzing nearly 50 years of breast cancer data in the United States has found an alarming shift in who is most affected by the disease.
Researchers discovered that while survival rates have improved greatly for older women over time, younger women are not seeing the same progress. In some groups, death rates are even rising.
The study was conducted by researchers from Houston Methodist and published in the journal npj Breast Cancer.
Breast cancer is the most common cancer affecting women in the United States aside from skin cancer. According to the American Cancer Society, about one in three new cancers diagnosed in women each year is breast cancer. It is also the second leading cause of cancer death among women, after lung cancer.
Over the past several decades, improvements in screening, surgery, chemotherapy, radiation therapy, and targeted treatments have helped many women survive breast cancer longer than before. However, the new study suggests these improvements have not been shared equally across all age groups and racial groups.
The researchers analyzed information from the Surveillance, Epidemiology and End Results program, often called SEER. This large national database has tracked cancer statistics across the United States since the 1970s.
The research team examined breast cancer data collected between 1975 and 2022. Their goal was to better understand how age, race, and tumor type interact to affect survival and mortality risks.
The study was led by Dr. Stephen Wong, director of the T. T. & W. F. Chao Center for BRAIN at Houston Methodist.
The findings showed that breast cancer deaths, which were once mainly concentrated among older women, are increasingly affecting younger women. This suggests that the pattern of breast cancer risk in the United States is changing.
One of the most concerning findings involved younger women from minority groups.
Researchers found that young Black women with triple-negative breast cancer remained the group with the highest overall risk. Triple-negative breast cancer is considered one of the most aggressive forms of breast cancer because it grows quickly and is harder to treat with common hormone therapies.
The study also found elevated mortality risks among Hispanic and Asian women younger than 50 years old, especially among those with triple-negative breast cancer.
Researchers said these risks may have been underestimated in earlier studies.
Dr. Wong explained that the findings show breast cancer risk is not shaped by a single factor alone. Age, race, and tumor biology appear to interact in complex ways that can strongly influence outcomes.
First author Lin Wang, a research fellow at Houston Methodist, said that studying these factors together helped reveal hidden patterns that might otherwise be missed.
The findings suggest that younger women from some racial and ethnic groups may need more attention in breast cancer screening, prevention, and treatment programs.
Triple-negative breast cancer has become a major concern for researchers because it does not respond to treatments that target estrogen, progesterone, or HER2 proteins. This limits treatment options and often leads to poorer outcomes.
Younger women diagnosed with aggressive cancers may also face unique challenges because breast cancer is often not expected at younger ages. Symptoms may sometimes be overlooked, or diagnosis may happen later when the disease is already more advanced.
The researchers believe future breast cancer care may need to become more personalized and population-specific. Instead of using broad recommendations for everyone, screening and treatment strategies may need to better consider age, race, and tumor subtype together.
The study also highlights the importance of continued research into why certain groups face higher risks.
Possible reasons could include differences in access to healthcare, delayed diagnosis, genetic factors, environmental exposures, treatment responses, and social inequalities. However, the study itself was not designed to determine exactly why these differences occur.
Even though survival rates overall have improved over recent decades, the findings show that not all women are benefiting equally from medical progress.
The researchers hope the study will encourage more targeted approaches to breast cancer prevention and treatment, especially for younger women in high-risk groups.
Overall, the study provides important evidence that breast cancer patterns in the United States are changing over time. One major strength of the research is the use of a very large national database covering almost 50 years of data.
However, the study mainly shows associations and cannot fully explain the causes behind the disparities. Future research will be needed to understand why younger women from some racial groups continue to experience worse outcomes and how healthcare systems can better address these risks.
If you care about breast cancer, please read studies about a major cause of deadly breast cancer, and this daily vitamin is critical to cancer prevention.
For more information about cancer, please see recent studies that new cancer treatment could reawaken the immune system, and results showing vitamin D can cut cancer death risk.
Source: Houston Methodist.
